Business
If only Ellume was an ASX share! Why it’s making big news today
For an unlisted company, Ellume certainly knows how to keep ASX investors talking. The Brisbane-based health company also made news last year. This was due to its announcement that the United States Food and Drug Administration (FDA) had endorsed one of its products.
As we discussed at the time, Ellume specialises in rapid diagnostic technology. The company had developed a rapid test for the COVID-19 infection. The test only costs around US$30. It can reportedly detect traces of coronavirus in as little as 15 minutes with a 94% sensitivity in detecting infection.
Following that endorsement from the FDA, Ellume ramped up plans to send more than 100,000 of its tests to the US. At the time, Ellume planned on delivering more than 5…
-
Business24 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
Noosa News24 hours agoYIMBYs vs NIMBYs as the battle for affordable housing moves into your backyard
-
Business20 hours agoThe ultimate Australian stocks to buy and hold for 10+ years
-
Noosa News16 hours agoLNP Premier David Crisafulli announces ‘Queensland’s royal commission’ into CFMEU